Giovanni Stefano Ugolini

Dr. Giovanni Stefano Ugolini


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2015 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
GUGiovanni Stefano Ugolini
Giovanni Stefano Ugolini
MRMarco Rasponi
Marco Rasponi
APAndrea Pavesi
Andrea Pavesi
Rosaria SantoroRosaria Santoro
Rosaria Santoro
RKRoger Kamm
Roger Kamm
Monica SonciniMonica Soncini
Monica Soncini

1 December 2018 in Cell Reports
Verified
Journal Article
Open access
SBSimone Bersini
Simone Bersini
MGMara Gilardi
Mara Gilardi
GUGiovanni Stefano Ugolini
Giovanni Stefano Ugolini
VSVeronica Sansoni
Veronica Sansoni
GTGiuseppe Talò
Giuseppe Talò
MMMatteo Moretti
Matteo Moretti
The integration of vascular structures into in vitro cultured tissues provides realistic models of complex tissue-vascular interactions. Despite the incidence and impact of muscle-wasting disorders, advanced in vitro systems are still far from recapitulating the environmental complexity of skeletal muscle. Our model comprises differentiated human muscle fibers enveloped by a sheath of human muscle-derived fibroblasts and supported by a vascular network with mural-like cells. Here, we demonstrate the induction of muscle-specific endothelium and the self-organization of endomysial muscle fibroblasts mediated by endothelial cells. We use this model to mimic the fibrotic environment characterizing muscular dystrophies and to highlight key signatures of fibrosis that are neglected or underestimated in traditional 2D monocultures. Overall, this vascularized meso-scale cellular construct finely recapitulates the human skeletal muscle environment and provides an advanced solution for in vitro studies of muscle physiology and pathology.

1 December 2019 in Cell Reports
Verified
Journal Article
Open access
AIAngelo Iannielli
Angelo Iannielli
GUGiovanni Stefano Ugolini
Giovanni Stefano Ugolini
CCChiara Cordiglieri
Chiara Cordiglieri
SBSimone Bido
Simone Bido
ARAlicia Rubio
Alicia Rubio
VBVania Broccoli
Vania Broccoli
Stem cell-derived neurons are generally obtained in mass cultures that lack both spatial organization and any meaningful connectivity. We implement a microfluidic system for long-term culture of human neurons with patterned projections and synaptic terminals. Co-culture of human midbrain dopaminergic and striatal medium spiny neurons on the microchip establishes an orchestrated nigro-striatal circuitry with functional dopaminergic synapses. We use this platform to dissect the mitochondrial dysfunctions associated with a genetic form of Parkinson's disease (PD) with OPA1 mutations. Remarkably, we find that axons of OPA1 mutant dopaminergic neurons exhibit a significant reduction of mitochondrial mass. This defect causes a significant loss of dopaminergic synapses, which worsens in long-term cultures. Therefore, PD-associated depletion of mitochondria at synapses might precede loss of neuronal connectivity and neurodegeneration. In vitro reconstitution of human circuitries by microfluidic technology offers a powerful system to study brain networks by establishing ordered neuronal compartments and correct synapse identity.

18 March 2017 in eLife
Verified
Journal Article
Open access
GUGiovanni Stefano Ugolini
Giovanni Stefano Ugolini
APAndrea Pavesi
Andrea Pavesi
MRMarco Rasponi
Marco Rasponi
GFGianfranco Beniamino Fiore
Gianfranco Beniamino Fiore
RKRoger Kamm
Roger Kamm
Monica SonciniMonica Soncini
Monica Soncini
Upon cardiac pathological conditions such as ischemia, microenvironmental changes instruct a series of cellular responses that trigger cardiac fibroblasts-mediated tissue adaptation and inflammation. A comprehensive model of how early environmental changes may induce cardiac fibroblasts (CF) pathological responses is far from being elucidated, partly due to the lack of approaches involving complex and simultaneous environmental stimulation. Here, we provide a first analysis of human primary CF behavior by means of a multi-stimulus microdevice for combined application of cyclic mechanical strain and controlled oxygen tension. Our findings elucidate differential human CFs responses to different combinations of the above stimuli. Individual stimuli cause proliferative effects (PHH3+ mitotic cells, YAP translocation, PDGF secretion) or increase collagen presence. Interestingly, only the combination of hypoxia and a simulated loss of contractility (2% strain) is able to additionally induce increased CF release of inflammatory and pro-fibrotic cytokines and matrix metalloproteinases.

8 April 2021 in Biofabrication
Verified
Journal Article
Open access
PDF file
RVRoberta Visone
Roberta Visone
GUGiovanni Stefano Ugolini
Giovanni Stefano Ugolini
DCDaniela Cruz-Moreira
Daniela Cruz-Moreira
SMSimona Marzorati
Simona Marzorati
SPStefano Piazza
Stefano Piazza
MRMarco Rasponi
Marco Rasponi
Cardiac toxicity still represents a common adverse outcome causing drug attrition and post-marketing withdrawal. The development of relevant in vitro models resembling the human heart recently opened the path towards a more accurate detection of drug-induced human cardiac toxicity early in the drug development process. Organs-on-chip have been proposed as promising tools to recapitulate in vitro the key aspects of the in vivo cardiac physiology and to provide a means to directly analyze functional readouts. In this scenario, a new device capable of continuous monitoring of electrophysiological signals from functional in vitro human hearts-on-chip is here presented. The development of cardiac microtissues was achieved through a recently published method to control the mechanical environment, while the introduction of a technology consisting in micro-electrode coaxial guides allowed to conduct direct and non-destructive electrophysiology studies. The generated human cardiac microtissues exhibited synchronous spontaneous beating, as demonstrated by multi-point and continuous acquisition of cardiac field potential, and expression of relevant genes encoding for cardiac ion-channels. A proof-of-concept pharmacological validation on three drugs proved the proposed model to potentially be a powerful tool to evaluate functional cardiac toxicity.

7 March 2017 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
GUGiovanni Stefano Ugolini
Giovanni Stefano Ugolini
RVRoberta Visone
Roberta Visone
ARAlberto Redaelli
Alberto Redaelli
MMMatteo Moretti
Matteo Moretti
MRMarco Rasponi
Marco Rasponi